Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: A two-edged weapon in chronic fatigue syndrome

Molecular Medicine Reports

Volumn 4, Issue 3, 2011, Pages 535-540

  Pasi, Annamaria ^a   Bozzini, Sara ^c   Carlo Stella, Nicoletta ^c   Martinetti, Miryam ^a   Bombardieri, Stefano ^d   De Silvestri, Annalisa ^b   Salvaneschi, Laura ^a   Cuccia, Mariaclara ^c  

^a Immunohaematology and Transfusion Center   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Chronic fatigue syndrome; HLA class I ligands; Killer cell immunoglobulin like receptors

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC FATIGUE SYNDROME; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DNA BINDING MOTIF; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFECTION; NATURAL KILLER CELL; PATHOGEN CLEARANCE; POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; FATIGUE SYNDROME, CHRONIC; HETEROZYGOTE; HLA-B ANTIGENS; HUMANS; ITALY; LIGANDS; LINKAGE DISEQUILIBRIUM; RECEPTORS, KIR;

XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 79953774706     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.447     Document Type: Article

References (34)

1. Fukuda K, Straus SE, Hickie I Sharpe MC, Dobbins JG and Komaroff A: The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121: 953-959, 1994. (Pubitemid 24370860)
2. Carruthers BM, Jain AK, DeMeirleir K, et al: Myalgic encephalomyelitis/ chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 11: 7-11, 2003.
3. Sharpe MC, Archard LC, Banatvala JE, et al: A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 84: 118-121, 1991.
4. Reeves WC, Lloyd A, Vernon SD, et al: Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution BMC Health Serv Res 3: 25-33, 2003.
5. Wessely S, Chalder T, Hirsch S, Willace P and Wright D: The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 87: 1449-1455, 1997. (Pubitemid 27415000)
6. Jason LA, Richman JA, Rademaker AW et al: A community-based study of chronic fatigue syndrome. Arch Intern Med 159: 2129-2137, 1999. (Pubitemid 29483152)
7. Carlo-Stella N and Cuccia M: Demographic and clinical aspects of an Italian patient population with chronic fatigue syndrome. Reumatismo 61: 285-289, 2009.
8. Devanur LD and Kerr JR: Chronic fatigue syndrome. J Clin Virol 37: 139-150, 2006. (Pubitemid 44548485)
9. Lombardi VC, Ruscetti FW, Das Gupta J, et al: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589, 2009.
10. Erlwein O, Kaye S, McQure MO, et al: Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 5: e8519, 2010.
11. Groom HC, Boucherit VC, Makinson K, et al: Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10, 2010.
12. Switzer WM, Jia H Hohn O, et al: Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States. Retrovirology 7: 57, 2010.
13. Lloyd A, White P, Wessely S, Sharpe M and Buchwald D: Comment on 'Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome'. Science 328: 825, 2010.
14. Van der Meer JW Netea MG, Galama JM and van Kuppeveld FJ: Comment on 'Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome'. Science 328: 825, 2010.
15. Natelson BH, Haghighi MH and Ponzio NM: Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol 9: 747-752, 2002. (Pubitemid 34773873)
16. Carlo-Stella N, Badulli C, De Silvestri A, et al: A first study of cytokine genomic polymophisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 24: 179-182, 2006. (Pubitemid 43826869)
17. Ortega-Hernandez OD, Cuccia M, Bozzini S, et al: Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms? Ann NY Acad Sci 1173: 589-599, 2009.
18. Carlo-Stella N, Bozzini S, De Silvestri A, et al: Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. Int J Immunopathol Pharmacol 22: 745-754, 2009.
19. Klimas NG, Salvato FR, Morgan R and Fletcher MA: Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 28: 1403-1410, 1990. (Pubitemid 20194439)
20. Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R and Moretta A: Human natural killer cells: their origin receptors and function. Eur J Immunol 32: 1205-1211, 2002. (Pubitemid 34546247)
21. Bontadini A, Testi M Cuccia M, et al: Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. J Transl Med 4: 44-52, 2006.
22. Uhrberg M, Parham P and Wernet P: Definition of gene content for nine common group B haplotypes of the caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenet 54: 221-229, 2002. (Pubitemid 34824132)
23. Parham P: MHC class I molecules and KIRS in human history, health and survival. Nat Rev Immunol 5: 201-214, 2006.
24. Foley B, De Santis D, Lathbury L, Christiansen F and Witt C: KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol 20: 555-563, 2008. (Pubitemid 351426049)
25. Martin MP, Gao X, Lee JH, et al: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 429-434, 2002. (Pubitemid 35154456)
26. Hansasuta P, Dong T, Thananchai H, et al: Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34: 1673-1679, 2004. (Pubitemid 39256049)
27. Warrington KJ, Takemura S, Goronzy JJ and Weyand CM: CD4+, CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 44: 13-20, 2001.
28. Martin MP, Nelson G, Lee JH, et al: Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169: 2818-2822, 2002. (Pubitemid 35013118)
29. Momot T, Koch S, Hunzelmann N, et al: Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50: 1561-1565, 2004. (Pubitemid 38608078)
30. Miyashita R, Tsuchiya N, Yabe T et al: Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangitis. Arthritis Rheum 54: 992-997, 2006.
31. Rajagopalan S and Long EO: Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 201: 1025-1029, 2005. (Pubitemid 40524669)
32. Santin I, de Nanclares GP, Calvo B, Gaafar A and Castano L: Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus. Hum Immunol 67: 118-124, 2006. (Pubitemid 43673913)
33. Taniguchi M and Kawabata M: KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection. Immunogenetics 61: 717-730, 2009.
34. Caligiuri M, Murray C, Buchwald D, et al: Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 139: 3306-3313, 1987. (Pubitemid 18021981)